IRS1 and Insulin resistance: This not only drives the sustained release of pro-inflammatory cytokines (such as IL-1β and TNF-α) but also disrupts insulin signaling through JNK/IRS-1 phosphorylation pathways, forming the pathological basis for chronic low-grade inflammation and insulin resistance (Hersoug et al., 2016).